Grigg, Claud M.
Levine Cancer Institute
2 papers on CoChatORCID 0000-0001-8847-5366
Most cited papers
- Verified
Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
Chowell, D., Morris, L. G. T., Grigg, C. M., Weber, J. K., Samstein, R. M., Makarov, V., Kuo, F., Kendall, S. M., Requena, D., Riaz, N., et al. (2018) · Science
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 1,142
- Verified
Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial.
Shu, C. A., Gainor, J. F., Awad, M. M., Chiuzan, C., Grigg, C. M., Pabani, A., Garofano, R. F., Stoopler, M. B., Cheng, S. K., White, A., et al. (2020) · The Lancet Oncology
Lung Cancer Diagnosis and TreatmentCancer Immunotherapy and Biomarkers
Cited by 623
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free